Download Q1 2012 - MRC CTU

HIV Resistance and Sequencing Related Publications
Q1 2012
Journal
Title
Author
Link
AIDS Research
and Therapy
HIV-1 Subtype distribution in
Morocco based on national
sentinel surveillance data 20042005
M. Akrim, et al.
Abstract
Antimicrobial
Agents and
Chemotherapy
N. C. T. Schopman, Abstract
Directed HIV-1 Evolution of
Protease Inhibitor Resistance by et al.
Second-Generation Short Hairpin
RNAs
G. J. Henderson, et
Interplay between Single
Resistance-Associated Mutations al.
in the HIV-1 Protease and Viral
Infectivity, Protease Activity, and
Inhibitor Sensitivity
Abstract
In Vitro Resistance Profile of the
Candidate HIV-1 Microbicide
Drug Dapivirine
S. M. Schader, et
al.
Standardized Comparison of the
Relative Impacts of HIV-1
Reverse Transcriptase (RT)
Mutations on Nucleoside RT
Inhibitor Susceptibility
G. L. Melikian, et al. Abstract
Differential Use of CCR5 by HIV1 Clinical Isolates Resistant to
Small Molecule CCR5
Antagonists
T. J. Henrich, et al.
Abstract
Abstract
Relative Impact of HIV-1 Reverse G. L. Melikian, et al. Abstract
Transcriptase Mutations on
Nucleoside RT Inhibitor
Susceptibility: A Standardized
Comparison
The role of natural
polymorphisms in HIV-1
CRF02_AG protease on
protease inhibitor
hypersusceptibility
A. F. A. Santos, et
al.
Abstract
Broad Phenotypic CrossResistance to Elvitegravir in HIVInfected Patients Failing on
Raltegravir-Containing Regimens
C. Garrido, et al.
Abstract
Journal of
virological
methods
Evaluation of genotypic
prediction of HIV-1 tropism using
population sequencing of
replicates
J. L. DE PAULA
FERREIRA, et al.
Abstract
Clinical
Infectious
Diseases
Incidence of HIV-1 Drug
Resistance Among Antiretroviral
Treatment–Naive Individuals
Starting Modern Therapy
Combinations
V. von Wyl, et al.
Abstract
A comparison of 3 regimens to
prevent nevirapine resistance
mutations in hiv-infected
pregnant women receiving a
single intrapartum dose of
nevirapine
R. B. Van Dyke, et
al.
Abstract
HIV-1 Subtype and Virological
Response to Antiretroviral
Therapy: Acquired Drug
Resistance
E. A. Soares, et al.
Abstract
Dried Blood Spot Specimens Are
a Suitable Alternative Sample
Type for HIV-1 Viral Load
Measurement and Drug
Resistance Genotyping in
Patients Receiving First-Line
Antiretroviral Therapy
E. K. Rottinghaus,
et al.
Abstract
Viremia and HIV-1 Drug
Resistance Mutations Among
Patients Receiving Second-Line
Highly Active Antiretroviral
Therapy in Chennai, Southern
India
S. Saravanan, et al. Abstract
Increasingly Successful Highly
Active Antiretroviral Therapy
Delays the Emergence of New
HLA Class I–Associated Escape
Mutations in HIV-1
D. J. H. F. Knapp,
et al.
Abstract
Patterns of HIV-1 Drug
Resistance After First-Line
R. L. Hamers, et al.
Abstract
Antiretroviral Therapy (ART)
Failure in 6 Sub-Saharan African
Countries: Implications for
Second-Line ART Strategies
HIV-1 Drug Resistance Resulting
from Antiretroviral Therapy Far
Exceeds that from Pre-Exposure
Prophylaxis
U. M. Parikh, et al.
Abstract
Intervirology
Epidemiology of Transmitted
Drug Resistance in Chronically
HIV-Infected Patients in
Germany: The RESINA Study
2001–2009
M. Oette, et al.
Abstract
PloS one
J. H. Brehm, et al.
Zidovudine (AZT) Monotherapy
Selects for the A360V Mutation in
the Connection Domain of HIV-1
Reverse Transcriptase
Abstract
HIV-1 Subtype D Infections
among Caucasians from
Northwestern Poland—
Phylogenetic and Clinical
Analysis
M. Parczewski, et
al.
Abstract
Emergence of Minor DrugResistant HIV-1 Variants after
Triple Antiretroviral Prophylaxis
for Prevention of Vertical HIV-1
Transmission
A. Hauser, et al.
Abstract
Virologic Failure of Protease
Inhibitor-Based Second-Line
Antiretroviral Therapy without
Resistance in a Large HIV
Treatment Program in South
Africa
J. H. Levison, et al.
Abstract
Low Prevalence of Transmitted
Drug Resistance in Patients
Newly Diagnosed with HIV-1
Infection in Sweden 2003–2010
A. Karlsson, et al.
Abstract
The Origin and Evolutionary
History of HIV-1 Subtype C in
Senegal
M. Jung, et al.
Abstract
BF Integrase Genes of HIV-1
Circulating in São Paulo, Brazil,
with a Recurrent Recombination
A. Iamarino, et al.
Abstract
Region
M. Bronze, et al.
HIV-1 Phenotypic Reverse
Transcriptase Inhibitor Drug
Resistance Test Interpretation Is
Not Dependent on the Subtype of
the Virus Backbone
Abstract
PLoS
Pathogens
M. R. Henn, et al.
Whole Genome Deep
Sequencing of HIV-1 Reveals the
Impact of Early Minor Variants
Upon Immune Recognition
During Acute Infection
Abstract
AIDS reviews
Temporal Changes in the
Epidemiology of Transmission of
Drug-Resistant HIV-1 across the
World
D. Frentz, et al.
A. K. Nyamache
Extent of drug resistance
mutations among HIV-1 positive
drug-naive patients in Kenya
abstract International HIV
pediatrics workshop in 2009
Cape Town South Africa on July
17-18th 2009. International
journal of reviews in antiviral
therapy Vol 6 A-05 pg 105 (2009)
Journal of
Antimicrobial
Chemotherapy
Abstract
Abstract
A non-infectious cell-based
phenotypic assay for the
assessment of HIV-1
susceptibility to protease
inhibitors
M. J. Buzon, et al.
Abstract
Frequency and patterns of
protease gene resistance
mutations in HIV-infected
patients treated with
lopinavir/ritonavir as their first
protease inhibitor
T. J. Barber, et al.
Abstract
Trends of transmitted drug
resistance of HIV-1 and its
impact on treatment response to
first-line antiretroviral therapy in
Taiwan
C. C. Lai, et al.
Abstract
High burden of transmitted HIV-1
drug resistance in Italian patients
carrying F1 subtype
M. Franzetti, et al.
Abstract
Journal of
Clinical
Microbiology
The role of polymorphisms at
position 89 in the HIV-1 protease
gene in the development of drug
resistance to HIV-1 protease
inhibitors
J. L. MartinezCajas, et al.
Abstract
HIV-1 protease mutation 82M
contributes to phenotypic
resistance to protease inhibitors
in subtype G
A. C. Palma, et al.
Abstract
Evolution of proviral DNA HIV-1
tropism under selective pressure
of maraviroc-based therapy
S. Baroncelli, et al.
Abstract
Prevalence of subtype-related
polymorphisms associated with
in vitro resistance to attachment
inhibitor BMS-626529 in HIV-1
‘non-B’-infected patients
C. Charpentier, et
al.
Abstract
Dual therapy based on a
ritonavir-boosted protease
inhibitor as a novel salvage
strategy for HIV-1-infected
patients on a failing antiretroviral
regimen
J. Burgos, et al.
Abstract
N. Mantovani, et al.
Analyses of transmitted
resistance and selective pressure
in HIV-1 naïve patients to
Raltegravir and failure HAART in
São Paulo, Brazil
Abstract
C. K. Woods, et al.
Abstract
Automating HIV drug resistance
genotyping with RECall, a freely
accessible sequence analysis
tool
Journal of the
International
Association of
Physicians in
AIDS Care
(JIAPAC)
Adherence and Preexisting Major E. M. Gardner, et
al.
Protease Inhibitor Resistance
Mutations are Associated with
Virologic Failure of a Dual-Class
Antiretroviral Regimen with
Inhibitors of HIV-1 Viral Protease
and Integrase
Journal of
Infectious
Diseases
Molecular Determinants of HIV-2
R5–X4 Tropism in the V3 Loop:
Development of a New
Genotypic Tool
B. Visseaux, et al.
Abstract
Abstract
AIDS
JAIDS - Journal
of Acquired
Immune
Deficiency
Syndromes
Transmission of the X4
Phenotype of HIV-1: Is There
Evidence Against the “Random
Transmission” Hypothesis?
C. Hedskog, et al.
Abstract
Study of Genotypic and
Phenotypic HIV-1 Dynamics of
Integrase Mutations During
Raltegravir Treatment: A Refined
Analysis by Ultra-Deep 454
Pyrosequencing
D. Armenia, et al.
Abstract
Second-line antiretroviral
treatment successfully resuppresses drug-resistant HIV-1
after first-line failure: prospective
cohort in sub-Saharan Africa
K. C. E. Sigaloff, et
al.
Abstract
Effects of short-course
zidovudine on the selection of
nevirapine-resistant HIV-1 in
women taking single-dose
nevirapine
M. A. Micek, et al.
Abstract
Blood mitochondrial DNA
mutations in HIV-infected women
and their infants exposed to
highly active antiretroviral
therapy during pregnancy
M. H. J. Jitratkosol,
et al.
Abstract
Tracing the origin and history of
HIV-1 subtype B'epidemic in
China by near full-length genome
analyses
Z. Li, et al.
Abstract
Relationship between minority
nonnucleoside reverse
transcriptase inhibitor resistance
mutations, adherence, and the
risk of virologic failure
J. Z. Li, et al.
Abstract
Discrepancies Between WHO
2009 and IAS-USA 2009 Lists for
Determining the Rate of
Transmitted HIV-1 Drug
Resistance: A Prospective Study
S. Sungkanuparph,
et al.
Abstract
Genotypic and phenotypic
characterization of HIV-1 isolates
obtained from patients on
L. Rimsky, et al.
Abstract
rilpivirine therapy experiencing
virologic failure in the phase 3
ECHO and THRIVE studies: 48week analysis
Journal of
Virology
The HIV-1 reverse transcriptase
M184I mutation enhances the
E138K-associated resistance to
rilpivirine and decreases viral
fitness
R. Kulkarni, et al.
Reverse Transcriptase
Substitution at Codons 208 and
228 Among TreatmentExperienced HIV-1 Subtype-C–
Infected Indian Patients Is
Strongly Associated With
Thymidine Analogue Mutations
S. Saravanan, et al. Abstract
AF4 HIV Drug Resistance in
Nigeria, a Cost-Effective New
Methodology
P. Kanki, et al.
Abstract
Does Genetic Diversity of HIV-1
Non-B Subtypes Differentially
Impact Disease Progression in
Treatment-Naive HIV-1–Infected
Individuals? A Systematic
Review of Evidence: 1996–2010
N. Pant Pai, et al.
Abstract
Molecular Epidemiology of HIV-1
Infection in Taiwan from 2005 to
2008: Further Spread of
CRF07_BC and Emergence of
CRF07_BC/Subtype B Dual
Infection
Y. J. Chen, et al.
Abstract
Does Genetic Diversity of HIV-1
Non-B Subtypes Differentially
Impact Disease Progression in
Treatment-Naive HIV-1 Infected
Individuals?: A Systematic
Review of Evidence: 1996-2010
N. P. Pai, et al.
Abstract
Rapid Expansion of a HIV-1
Subtype F Cluster of Recent
Origin Among Men Who Have
Sex With Men in Galicia, Spain
M. Thomson, et al.
Abstract
Mutations of Gln64 in the HIV-1
gp41 N-Terminal Heptad Repeat
X. Yu, et al.
Abstract
Abstract
Render Viruses Resistant to
Peptide HIV Fusion Inhibitors
Targeting the gp41 Pocket
P. K. Quashie, et
Characterization of the R263K
Mutation in HIV-1 Integrase That al.
Confers Low-Level Resistance to
the Second-Generation Integrase
Strand Transfer Inhibitor
Dolutegravir
Abstract
Vicriviroc Resistance Decay and
Relative Replicative Fitness in
HIV-1 Clinical Isolates Under
Sequential Drug Selection
Pressures
A. M. N. Tsibris, et
al.
Abstract
Uncommon pathways of immune
escape attenuate HIV-1
integrase replication capacity
M. A. Brockman, et
al.
Abstract
Molecular
biology and
evolution
Inconsistencies in estimating the
age of HIV-1 subtypes due to
heterotachy
J. O. Wertheim, et
al.
Abstract
AIDS Research
and Human
Retroviruses
HIV Type 1 Viral Encephalitis
After Development of Viral
Resistance to Plasma
Suppressive Antiretroviral
Therapy
M. del Palacio
Tamarit, et al.
Abstract
C. Charpentier, et
Virological Response and
Resistance Profiles After 18 to 30 al.
Months of First-or Second-/ThirdLine Antiretroviral Treatment: A
Cross-Sectional Evaluation in
HIV Type 1-Infected Children
Living in the Central African
Republic
Abstract
Monitoring of HIV Type 1 DNA
Load and Drug Resistance in
Peripheral Blood Mononuclear
Cells During Suppressive
Antiretroviral Therapy Does Not
Predict Virologic Failure
I. A. Beck, et al.
Abstract
HIV Type 1 Subtype Surveillance
in Central Kenya
S. Kageha, et al.
Abstract
Drug Resistance Pattern of HIV
Type 1 Isolates Sampled in 2007
H. O. Ajoge, et al.
Abstract
from Therapy-Naive Pregnant
Women in North-Central Nigeria
Accumulation of HIV Drug
Resistance Mutations in Patients
Failing First-Line Antiretroviral
Treatment in South Africa
K. C. E. Sigaloff, et
al.
Abstract
M. M. Santoro, et
COMPARATIVE ANALYSIS OF
al.
DRUG-RESISTANCE AMONG
B-AND THE MOST PREVALENT
NON-B HIV-1 SUBTYPES (C, F
AND CRF02_AG) IN ITALY
Abstract
Drug resistance mutations in the
HIV-1 protease and reverse
transcriptase genes in
antiretroviral-naïve Vietnamese
children
Q. D. Trinh, et al.
Abstract
Drug resistance mutations of
HIV-1 non-B viruses to integrase
inhibitors in treatment-naïve
patients from sub-Saharan
countries and discordant
interpretations
M. Monleau, et al.
Abstract
Unusual insertion and deletion at
codon 67 and 69 of HIV-1
subtype C reverse transcriptase
among first-line HAART failing
South Indian patients:
association with other resistance
mutations
S. Saravanan, et al. Abstract
High Prevalence of Transmitted
Antiretroviral Drug Resistance
Among Newly HIV Type 1
Diagnosed Adults in Mombasa,
Kenya
K. C. E. Sigaloff, et
al.
Abstract
Recombination between Variants
from Genital Tract and Plasma:
Evolution of Multidrug-Resistant
HIV-1
K. Kemal, et al.
Abstract
Phylodynamic and
Phylogeographic Patterns of the
HIV-1 Subtype F1 Parenteral
Epidemic in Romania
J. L. Mbisa, et al.
Abstract
Journal of
Medical
Virology
The analysis of near full-length
genome sequences of HIV-1
subtype A viruses from Russia
supports the monophyly of major
intrasubtype clusters
A. FernándezGarcía, et al.
Abstract
HIV-1 Coreceptor Tropism,
CCR5 Genotype and Integrase
Inhibitor Resistance Profiles in
Vietnam–Implications for the
Introduction of New Antiretroviral
Regimens
Q. P. Luu, et al.
Abstract
No increase of drug-resistant
HIV-1 prevalence among drugnaïve individuals in Northern
Vietnam
V. T. Tran, et al.
Abstract
Genetic Diversity and Naturally
Polymorphisms in HIV-1
Integrase Isolates from Maputo,
Mozambique: Implications for
Integrase Inhibitors
M. F. Oliveira, et al.
Abstract
C. K. Lee, et al.
An in‐ house HIV genotyping
assay for the detection of drug
resistance mutations in
Southeast Asian patients infected
with HIV1
Abstract
Prevalence of etravirine
resistance associated mutations
in HIV1 strains isolated from
infected individuals failing
efavirenz: Comparison between
subtype B and non B genetic
variants
J. Pereira Vaz, et
al.
Minority HIV1 resistant variants
in recent infection and in patients
who failed first‐ line antiretroviral
therapy with no detectable
resistance associated mutations
in Thailand
H. Le Nguyen, et al. Abstract
Characterization of drug
resistance mutations in naïve
and ART‐ treated patients
infected with HIV‐ 1 in Yaounde,
Cameroon
L. Ceccarelli, et al.
Abstract
Abstract
Tropical
Medicine &
International
Health
The role of sexually transmitted
infections in the evolution of the
South African HIV epidemic
L. F. Johnson, et al. Abstract
HIV medicine
Predictive value of HIV‐ 1
replication capacity and
phenotypic susceptibility scores
in antiretroviral
treatment‐ experienced patients
R. Bedimo, et al.
Abstract
C. Delaugerre, et
Comparison of resistance
al.
mutation patterns in historical
plasma HIV RNA genotypes with
those in current proviral HIV DNA
genotypes among extensively
treated patients with suppressed
replication
Abstract
Clinical
Microbiology
and Infection
Evolution of transmitted HIV1
drug resistance in HIV1‐ infected
patients in Italy since 2000 to
2010
M. Colafigli, et al.
Abstract
Biochemistry
HIV-1 protease with 20 mutations J. Agniswamy, et
al.
exhibits extreme resistance to
clinical inhibitors through
coordinated structural
rearrangements
Abstract
Science's STKE
HIV-1 Clinical Isolates Resistant
to CCR5 Antagonists Exhibit
Delayed Entry Kinetics That Are
Corrected in the Presence of
Drug
O. Putcharoen, et
al.
Abstract
Journal of the
International
AIDS Society
Emergence of HIV-1 drug
resistance mutations among
antiretroviral-naive HIV-1infected patients after rapid
scaling up of antiretroviral
therapy in Thailand
S. Sungkanuparph,
et al.
Abstract
BMC Medical
Research
Methodology
Effect of misclassification of
antiretroviral treatment status on
the prevalence of transmitted
HIV-1 drug resistance
H. Castro, et al.
Abstract
AIDS Research
and Treatment
Trends in Decline of Antiretroviral K. Buchacz, et al.
Resistance among ARVExperienced Patients in the HIV
Abstract
Outpatient Study: 1999&# 8211;
2008
Impact of Novel Resistance
Profiles in HIV-1 Reverse
Transcriptase on Phenotypic
Resistance to NVP
L. Jiao, et al.
Abstract
Prevalence of HIV Drug
Resistance Mutations in HIV
Type 1 Isolates in Antiretroviral
Therapy Naïve Population from
Northern India
S. Sinha, et al.
Abstract
International
journal of STD
& AIDS
Evaluation of HIV-1 resistance to
antiretroviral drugs among 150
patients after six months of
therapeutic interruption
E. Kalmar, et al.
Abstract
The Lancet
Infectious
Diseases
Dampening the effect of drug
resistance in HIV: a leap forward
J. D. Lundgren, et
al.
Abstract
Scientific
Reports
Factors limiting the transmission
of HIV mutations conferring drug
resistance: fitness costs and
genetic bottlenecks
B. G. Wagner, et al. Abstract
International
Journal of
Molecular
Epidemiology
and Genetics
K. Diallo, et al.
Comparison of HIV-1 resistance
profiles in plasma RNA versus
PBMC DNA in heavily treated
patients in Honduras, a resourcelimited country
Abstract
Clinical
Infectious
Diseases
Poorer Immunologic Outcome on
Treatment Among Patients
Infected with HIV-1 Non-B
Subtypes Compared to Subtype
B in Singapore
L. K. Lee, et al.
Abstract
Antiviral
Therapy
HIV-1 drug resistance in
antiretroviral-naive individuals
with HIV-1-associated
tuberculous meningitis initiating
antiretroviral therapy in Vietnam
V. P. Thao, et al.
Abstract
Retrovirology
Timing and source of subtype-C
HIV-1 superinfection in the newly
infected partner of Zambian
couples with disparate viruses
C. S. Kraft, et al.
Abstract
Modulation of HIV-1 Gag NC/p1
N. M. van
Abstract
cleavage efficiency affects
protease inhibitor resistance and
viral replicative capacity
Maarseveen, et al.
Journal of
Molecular
Structure
Multiple drug resistant
mechanisms against darunavir,
amprenavir, and nelfinavir of
HIV-1 PR
X. Liu, et al.
Abstract
Virology
Ultra-Deep Sequencing of HIV-1
Reverse Transcriptase Before
Start of an NNRTI-based
Regimen in Treatment-naive
Patients
P. Messiaen, et al.
Abstract
Journal of
Clinical
Virology
Automated sequence analysis
and editing software for HIV drug
resistance testing
D. Struck, et al.
Abstract
HIV-1 subtypes D and F are
prevalent in Guinea Conakry
G. Freimanis, et al.
Abstract
Naturally occurring resistance
mutations to HIV-1 entry
inhibitors in subtypes B, C, and
CRF31_BC
L. A. L. Araújo, et
al.
Abstract
Development and evaluation of
an assay for HIV-1 protease and
reverse transcriptase drug
resistance genotyping of all
major group-M subtypes
S. C. Aitken, et al.
Abstract
HIV-1 mother-to-child
transmission and drug resistance
among Brazilian pregnant
women with high access to
diagnosis and prophylactic
measures
K. C. Alcântara, et
al.
Abstract
Infection,
Genetics and
Evolution
Phylodynamics of HIV-1 subtype
F1 in Angola, Brazil and
Romania
G. Bello, et al.
Abstract
Archives of
Virology
Impaired CD4+ cell recovery
during antiretroviral therapy in
patients with HIV resistance
mutations
K. W. Sühs, et al.
Abstract
Methods in
molecular
biology
Decomposing the Energetic
Impact of Drug-Resistant
Mutations: The Example of HIV-1
Y. Cai, et al.
Abstract
Protease–DRV Binding